tiprankstipranks
Trending News
More News >
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (HK:0874)
:0874

Guangzhou Baiyunshan Pharmaceutical Holdings Company (0874) Price & Analysis

Compare
0 Followers

0874 Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

3.70%92.82%
Insiders
3.70%
Mutual Funds
― Other Institutional Investors
92.82% Public Companies and
Individual Investors

0874 FAQ

What was Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s price range in the past 12 months?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H lowest stock price was HK$15.76 and its highest was HK$24.00 in the past 12 months.
    What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s market cap?
    Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s market cap is $44.46B.
      When is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s upcoming earnings report date?
      Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s upcoming earnings report date is Aug 16, 2025 which is in 43 days.
        How were Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s earnings last quarter?
        Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H released its earnings results on Apr 29, 2025. The company reported HK$1.227 earnings per share for the quarter, beating the consensus estimate of HK$0.603 by HK$0.624.
          Is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H overvalued?
          According to Wall Street analysts Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H pay dividends?
            Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H pays a Annually dividend of HK$0.436 which represents an annual dividend yield of 2.51%. See more information on Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H dividends here
              What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s EPS estimate?
              Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H have?
              Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H has 219,900,000 shares outstanding.
                What happened to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s price movement after its last earnings report?
                Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H reported an EPS of HK$1.227 in its last earnings report, beating expectations of HK$0.603. Following the earnings report the stock price went down -1.783%.
                  Which hedge fund is a major shareholder of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H?
                  Currently, no hedge funds are holding shares in HK:0874

                  Guangzhou Baiyunshan Pharmaceutical Holdings Company Stock Smart Score

                  Company Description

                  Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H

                  Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People's Republic of China and internationally. The company operates through four segments: Great Southern TCM, Great Commerce, Great Health, and Others. It is also involved in the wholesale, retail, import, and export of Western and Chinese medicines, and medical apparatus and instruments; and research and development, production, and sale of beverages, food, healthcare products, pre-packaging food, dairy products, tablets, capsules, lozenges, injections, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical care, health management, health preservation, elderly care, etc.; and provides commercial and advertising services. As of December 31, 2021, it had 154 retail chain pharmacy outlets, which included 22 Cai Zhi Lin pharmacy outlets, 36 Jian Min pharmacy outlets, 51 GPC Prescription Pharmacy outlets, and 23 Hainan Guangyao Chenfei Pharmaceutical Chain Co., Ltd outlets, as well as 22 retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  The United Laboratories International Holdings
                  Livzon Pharmaceutical Group
                  Shanghai Fosun Pharmaceutical (Group) Co
                  China Resources Pharmaceutical Group Ltd.
                  Grand Pharmaceutical Group Limited
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis